Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy

Neurology. 2005 Jul 26;65(2):331-2. doi: 10.1212/01.wnl.0000168865.36352.53.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Atrophy / chemically induced
  • Atrophy / genetics
  • Atrophy / physiopathology
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Carboplatin / adverse effects
  • Carcinoma / drug therapy*
  • Carcinoma / secondary
  • Cerebellar Ataxia / chemically induced*
  • Cerebellar Ataxia / genetics*
  • Cerebellar Ataxia / physiopathology
  • Cerebellum / drug effects
  • Cerebellum / pathology
  • Cerebellum / physiopathology
  • Drug Resistance / genetics
  • Female
  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Syndrome / genetics*
  • Genetic Predisposition to Disease / genetics
  • Heterozygote
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Magnetic Resonance Imaging

Substances

  • FMR1 protein, human
  • Fragile X Mental Retardation Protein
  • Carboplatin